Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | GBA1 | P04062 | 1/20 | 0.32 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24480318 | 0.84 | GNAO1 (0.35) | ACHEGBA1GNAO1CACNA2D1CACNA1B | |
| SCHEMBL24480848 | 0.84 | L3MBTL3 (0.34) | ACHEGBA1GNAO1CACNA2D1CACNA1B | |
| SCHEMBL24185940 | 0.84 | HRH3 (0.33) | — | |
| SCHEMBL24480580 | 0.83 | GNAO1 (0.34) | ACHEGBA1GNAO1CACNA2D1CACNA1B | |
| SCHEMBL25027129 | 0.82 | ACHE (0.53) | ACHEGBA1GNAO1CACNA2D1CACNA1B | |
| SCHEMBL29317239 | 0.81 | ACHE (0.41) | ACHEGBA1CACNA2D1CACNA1BCACNB1 | |
| SCHEMBL26752530 | 0.81 | HRH3 (0.33) | — | |
| SCHEMBL25856316 | 0.80 | HRH3 (0.31) | — | |
| SCHEMBL25507796 | 0.78 | HRH3 (0.31) | — | |
| SCHEMBL24480587 | 0.78 | GBA1 (0.32) | GBA1GNAO1CACNA2D1CACNA1BCACNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023131167-A1 | COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF | 海思科医药集团股份有限公司 | 2023-07-13 | — | — | WO | disclosed |